Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2010

Open Access 01-12-2010 | Research

The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia

Authors: Pengfei Zhu, Yanxia Ning, Liangqing Yao, Mo Chen, Congjian Xu

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2010

Login to get access

Abstract

Background

Epithelial ovarian cancer is one of the most malignant cancers in women because metastasis occurs in the most of patients by the time of diagnosis. Cancer cells have strong capacity to form angiogenesis or vasculogenic mimicry, which plays the major role in its malignant phenotype. Vasculogenic mimicry might contribute to the failure of the angiogenesis-targeted therapy strategies. Under the microenvironment of the tumor, hypoxia is the most common phenomena because of the vast energy and oxygen consuming. In the present study, the endothelial-like cells induced by hypoxia from SKOV-3 and ES-2 ovarian cancer cells were harvested to investigate the changes in their biological behaviors.

Methods

The endothelial-like cells from SKOV-3 and ES-2 cells were harvested by laser capture microdissection. The biological behaviors of the endothelial-like cells, including proliferation, cell cycle, apoptosis, invasion and telomerase activity were determined by MTT, FCM, Transwell chamber and TRAP-ELISA methods. HIF-1α is the most important factor for the behavior changes under hypoxic condition. Some other genes relative to biological behaviors are also changes following the changes of HIF-1α. In order to elucidate the underlying mechanisms for these changes by hypoxia, the relative genes expressions including HIF-1α, CyclinD1, Flk-1, VEGF, p53 and V-src were determined by real-time PCR.

Results

SKOV-3 and ES-2 cells were resistant to hypoxia by adoption of proliferation, apoptosis, differentiation and invasion. Combined with other studies, the more poorly cancer cells differentiate, the more strongly cells are resistant to hypoxia, the more possible to form vasculogenic mimicry. The changes in the expression of HIF-1α, and HIF-1α-dependent VEGF, Flk-1, Cyclin D1, and HIF-1α-independent p53 have been involved in this process.

Conclusions

HIF-1α took an important role in the behavioral changes of SKOV-3 and ES-2 cells by hypoxia. At the same time, other mechanisms were also involved in this process.
Appendix
Available only for authorised users
Literature
1.
go back to reference Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ: Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res. 2000, 60: 5334-5339. Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ: Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res. 2000, 60: 5334-5339.
2.
go back to reference Demeter A, Varkonyi T, Csapo Z, Szantho A, Olah J, Papp Z: [Assessment of prognostic factors in common ovarian tumors of varying malignancy]. Magy Onkol. 2004, 48: 259-265. Demeter A, Varkonyi T, Csapo Z, Szantho A, Olah J, Papp Z: [Assessment of prognostic factors in common ovarian tumors of varying malignancy]. Magy Onkol. 2004, 48: 259-265.
3.
go back to reference Janic B, Arbab AS: The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization. ScientificWorldJournal. 2010, 10: 1088-1099.CrossRef Janic B, Arbab AS: The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization. ScientificWorldJournal. 2010, 10: 1088-1099.CrossRef
4.
go back to reference Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 1994, 79: 185-188. 10.1016/0092-8674(94)90187-2.CrossRef Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 1994, 79: 185-188. 10.1016/0092-8674(94)90187-2.CrossRef
5.
go back to reference Folkman J: Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995, 333: 1757-1763. 10.1056/NEJM199512283332608.CrossRef Folkman J: Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995, 333: 1757-1763. 10.1056/NEJM199512283332608.CrossRef
6.
go back to reference Rasila KK, Burger RA, Smith H, Lee FC, Verschraegen C: Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. Int J Gynecol Cancer. 2005, 15: 710-726. 10.1111/j.1525-1438.2005.00132.x.CrossRef Rasila KK, Burger RA, Smith H, Lee FC, Verschraegen C: Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. Int J Gynecol Cancer. 2005, 15: 710-726. 10.1111/j.1525-1438.2005.00132.x.CrossRef
7.
go back to reference Millimaggi D, Mari M, D' Ascenzo S, Giusti I, Pavan A, Dolo V: Vasculogenic mimicry of human ovarian cancer cells: role of CD147. Int J Oncol. 2009, 35: 1423-1428. Millimaggi D, Mari M, D' Ascenzo S, Giusti I, Pavan A, Dolo V: Vasculogenic mimicry of human ovarian cancer cells: role of CD147. Int J Oncol. 2009, 35: 1423-1428.
8.
go back to reference Folberg R, Hendrix MJ, Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000, 156: 361-381.CrossRef Folberg R, Hendrix MJ, Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000, 156: 361-381.CrossRef
9.
go back to reference Tang HS, Feng YJ, Yao LQ: Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer. Int J Gynecol Cancer. 2009, 19: 605-610. 10.1111/IGC.0b013e3181a389e6.CrossRef Tang HS, Feng YJ, Yao LQ: Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer. Int J Gynecol Cancer. 2009, 19: 605-610. 10.1111/IGC.0b013e3181a389e6.CrossRef
10.
go back to reference Vaupel P, Mayer A: Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007, 26: 225-239. 10.1007/s10555-007-9055-1.CrossRef Vaupel P, Mayer A: Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007, 26: 225-239. 10.1007/s10555-007-9055-1.CrossRef
11.
go back to reference Yao LQ, Feng YJ, Ding JX, Jing HM, Xu CJ, Chen SF, Su M, Yin LH: Characteristics and differentiated mechanism of vascular endothelial cells-like derived from epithelial ovarian cancer cells induced by hypoxia. Int J Oncol. 2007, 30: 1069-1075. Yao LQ, Feng YJ, Ding JX, Jing HM, Xu CJ, Chen SF, Su M, Yin LH: Characteristics and differentiated mechanism of vascular endothelial cells-like derived from epithelial ovarian cancer cells induced by hypoxia. Int J Oncol. 2007, 30: 1069-1075.
12.
go back to reference Su M, Feng YJ, Yao LQ, Cheng MJ, Xu CJ, Huang Y, Zhao YQ, Jiang H: Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo. Int J Gynecol Cancer. 2008, 18: 476-486. 10.1111/j.1525-1438.2007.01034.x.CrossRef Su M, Feng YJ, Yao LQ, Cheng MJ, Xu CJ, Huang Y, Zhao YQ, Jiang H: Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo. Int J Gynecol Cancer. 2008, 18: 476-486. 10.1111/j.1525-1438.2007.01034.x.CrossRef
13.
go back to reference Yao LQ, Feng YJ, Ding JX, Xu CJ, Jin HY, Yin LH: [Primary study of vasculogenic mimicry induced by hypoxia in epithelial ovarian carcinoma]. Zhonghua Fu Chan Ke Za Zhi. 2005, 40: 662-665. Yao LQ, Feng YJ, Ding JX, Xu CJ, Jin HY, Yin LH: [Primary study of vasculogenic mimicry induced by hypoxia in epithelial ovarian carcinoma]. Zhonghua Fu Chan Ke Za Zhi. 2005, 40: 662-665.
14.
go back to reference Zhu Y, Lin JH, Liao HL, Friedli O, Verna L, Marten NW, Straus DS, Stemerman MB: LDL induces transcription factor activator protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol. 1998, 18: 473-480.CrossRef Zhu Y, Lin JH, Liao HL, Friedli O, Verna L, Marten NW, Straus DS, Stemerman MB: LDL induces transcription factor activator protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol. 1998, 18: 473-480.CrossRef
15.
go back to reference Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ: Molecular determinants of ovarian cancer plasticity. Am J Pathol. 2001, 158: 1279-1288.CrossRef Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ: Molecular determinants of ovarian cancer plasticity. Am J Pathol. 2001, 158: 1279-1288.CrossRef
16.
go back to reference Hopfl G, Wenger RH, Ziegler U, Stallmach T, Gardelle O, Achermann R, Wergin M, Kaser-Hotz B, Saunders HM, WIlliams KJ, Stratfrod IJ, Gassmann M, Desbaillets I: Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Res. 2002, 62: 2962-2970. Hopfl G, Wenger RH, Ziegler U, Stallmach T, Gardelle O, Achermann R, Wergin M, Kaser-Hotz B, Saunders HM, WIlliams KJ, Stratfrod IJ, Gassmann M, Desbaillets I: Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Res. 2002, 62: 2962-2970.
17.
go back to reference Zhi X, Chen S, Zhou P, Shao Z, Wang L, Ou Z, Yin L: RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin Exp Metastasis. 2007, 24: 439-448. 10.1007/s10585-007-9081-y.CrossRef Zhi X, Chen S, Zhou P, Shao Z, Wang L, Ou Z, Yin L: RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin Exp Metastasis. 2007, 24: 439-448. 10.1007/s10585-007-9081-y.CrossRef
18.
go back to reference Weljie AM, Jirik FR: Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect. Int J Biochem Cell Biol. 2010, Weljie AM, Jirik FR: Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect. Int J Biochem Cell Biol. 2010,
19.
go back to reference Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999, 155: 739-752.CrossRef Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999, 155: 739-752.CrossRef
20.
go back to reference Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM, Hendrix MJ: Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol. 2004, 190: 899-909. 10.1016/j.ajog.2004.02.011.CrossRef Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM, Hendrix MJ: Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol. 2004, 190: 899-909. 10.1016/j.ajog.2004.02.011.CrossRef
21.
go back to reference Liu JP, Li H: Telomerase in the ovary. Reproduction. 2010, 140: 215-222. 10.1530/REP-10-0008.CrossRef Liu JP, Li H: Telomerase in the ovary. Reproduction. 2010, 140: 215-222. 10.1530/REP-10-0008.CrossRef
22.
go back to reference Ozmen B, Duvan CI, Gumus G, Sonmezer M, Gungor M, Ortac F: The role of telomerase activity in predicting early recurrence of epithelial ovarian cancer after first-line chemotherapy: a prospective clinical study. Eur J Gynaecol Oncol. 2009, 30: 303-308. Ozmen B, Duvan CI, Gumus G, Sonmezer M, Gungor M, Ortac F: The role of telomerase activity in predicting early recurrence of epithelial ovarian cancer after first-line chemotherapy: a prospective clinical study. Eur J Gynaecol Oncol. 2009, 30: 303-308.
23.
go back to reference Lubin J, Markowska J, Markowska A, Stanislawiak J, Lukaszewski T: Activity of telomerase in ovarian cancer cells. Clinical implications. Clin Exp Obstet Gynecol. 2009, 36: 91-96. Lubin J, Markowska J, Markowska A, Stanislawiak J, Lukaszewski T: Activity of telomerase in ovarian cancer cells. Clinical implications. Clin Exp Obstet Gynecol. 2009, 36: 91-96.
24.
go back to reference Xie X, Hsu JL, Choi MG, Xia W, Yamaguchi H, Chen CT, Trinh BQ, Lu Z, Wokf JK, Bast RC, Hung MC: A novel hTERT promoter-driven E1A therapeutic for ovarian cancer. Mol Cancer Ther. 2009, 8: 2375-2382. 10.1158/1535-7163.MCT-09-0056.CrossRef Xie X, Hsu JL, Choi MG, Xia W, Yamaguchi H, Chen CT, Trinh BQ, Lu Z, Wokf JK, Bast RC, Hung MC: A novel hTERT promoter-driven E1A therapeutic for ovarian cancer. Mol Cancer Ther. 2009, 8: 2375-2382. 10.1158/1535-7163.MCT-09-0056.CrossRef
25.
go back to reference Li H, Simpson ER, Liu JP: Oestrogen, telomerase, ovarian ageing and cancer. Clin Exp Pharmacol Physiol. 2010, 37: 78-82. 10.1111/j.1440-1681.2009.05238.x.CrossRef Li H, Simpson ER, Liu JP: Oestrogen, telomerase, ovarian ageing and cancer. Clin Exp Pharmacol Physiol. 2010, 37: 78-82. 10.1111/j.1440-1681.2009.05238.x.CrossRef
26.
go back to reference Spinella F, Rosano L, Del DM, Di C, Nicotra MR, Natali PG, Bagnato A: Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells. PLoS One. 2010, 5: e11241-10.1371/journal.pone.0011241.CrossRef Spinella F, Rosano L, Del DM, Di C, Nicotra MR, Natali PG, Bagnato A: Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells. PLoS One. 2010, 5: e11241-10.1371/journal.pone.0011241.CrossRef
27.
go back to reference Goteri G, Lucarini G, Zizzi A, Rubini C, Di PR, Tranquilli AL, Ciavattini A: Proangiogenetic molecules, hypoxia-inducible factor-1alpha and nitric oxide synthase isoforms in ovarian endometriotic cysts. Virchows Arch. 2010, 456: 703-710. 10.1007/s00428-010-0929-1.CrossRef Goteri G, Lucarini G, Zizzi A, Rubini C, Di PR, Tranquilli AL, Ciavattini A: Proangiogenetic molecules, hypoxia-inducible factor-1alpha and nitric oxide synthase isoforms in ovarian endometriotic cysts. Virchows Arch. 2010, 456: 703-710. 10.1007/s00428-010-0929-1.CrossRef
28.
go back to reference Knechtel G, Szkandera J, Stotz M, Hofmann G, Langsenlehner U, Krippl P, Samonigg H, Renner W, Langner C, Dehchamani D, Gerger A: Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog. 2010, 49: 805-809. Knechtel G, Szkandera J, Stotz M, Hofmann G, Langsenlehner U, Krippl P, Samonigg H, Renner W, Langner C, Dehchamani D, Gerger A: Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog. 2010, 49: 805-809.
29.
go back to reference Miyazawa M, Yasuda M, Fujita M, Hirabayashi K, Hirasawa T, Kajiwara H, Muranmatsu T, Miyazaki S, Harasawa M, Matsui N, Ogane N, Murakami M, Mikami M, Yanase T, Osamura RY: Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway. J Obstet Gynaecol Res. 2010, 36: 448-453. 10.1111/j.1447-0756.2009.01127.x.CrossRef Miyazawa M, Yasuda M, Fujita M, Hirabayashi K, Hirasawa T, Kajiwara H, Muranmatsu T, Miyazaki S, Harasawa M, Matsui N, Ogane N, Murakami M, Mikami M, Yanase T, Osamura RY: Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway. J Obstet Gynaecol Res. 2010, 36: 448-453. 10.1111/j.1447-0756.2009.01127.x.CrossRef
30.
go back to reference Villaume K, Blanc M, Gouysse G, Walter T, Couderc C, Nejjari M, Vercherat C, Cordire-Bussat M, Roche C, Scoazec JY: VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway. Neuroendocrinology. 2010, 91: 268-278. 10.1159/000289569.CrossRef Villaume K, Blanc M, Gouysse G, Walter T, Couderc C, Nejjari M, Vercherat C, Cordire-Bussat M, Roche C, Scoazec JY: VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway. Neuroendocrinology. 2010, 91: 268-278. 10.1159/000289569.CrossRef
31.
go back to reference Zeng M, Kikuchi H, Pino MS, Chung DC: Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. PLoS One. 2010, 5: e10966-10.1371/journal.pone.0010966.CrossRef Zeng M, Kikuchi H, Pino MS, Chung DC: Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. PLoS One. 2010, 5: e10966-10.1371/journal.pone.0010966.CrossRef
Metadata
Title
The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia
Authors
Pengfei Zhu
Yanxia Ning
Liangqing Yao
Mo Chen
Congjian Xu
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2010
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-29-124

Other articles of this Issue 1/2010

Journal of Experimental & Clinical Cancer Research 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine